XFOR

X4 Pharmaceuticals Inc.

Price

$4.16

return (12m)

41.98%

p/e

-5.95

p/bv

3.45

DIVIDEND YIELD

0.00%

XFOR price

X4 Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XFOR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.74%

3 months

2.97%

1 year

41.98%

2 years

-80.41%

5 years

-97.18%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals XFOR

Valuation

P/E

-5.95

Sector -4.38

Industry -4.38

P/BV

3.45

Sector 2.02

Industry 2.02

P/Revenue (PSR)

33.86

Sector -4.40

Industry -4.40

EV/EBITDA

-31.22

Sector -263.09

Industry -263.09

EV/EBIT

-28.99

Sector -702.90

Industry -702.90

P/EBITDA

-6.73

Sector -4.39

Industry -4.39

P/EBIT

-6.59

Sector -4.73

Industry -4.73

P/Total Assets

2.12

Sector 1.49

Industry 1.49

P/Net Current Assets

4.43

Sector -11.70

Industry -11.70

P/Working Capital

2.69

Sector -3.19

Industry -3.19

EPS

-0.72

Sector -2.14

Industry -2.14

BVPS

1.23

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

81.45%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-147.45%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-158.80%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-57.99%

Sector -65.14%

Industry -65.14%

ROA

-35.62%

Sector -65.53%

Industry -65.53%

ROIC

-182.71%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

11.30

Sector 2.90

Industry 2.90

Net Debt / EBITDA

10.10

Sector -6.07

Industry -6.07

Net Debt / EBIT

9.38

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.84

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.49

Sector -0.05

Industry -0.05

Equity/Assets

0.61

Sector 0.41

Industry 0.41

Liabilities/Assets

0.39

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.32%

Sector -

Industry -

Fundamentals XFOR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XFOR X4 Pharmaceuticals Inc.	$4.16	67.07%	0.00%	-5.95	3.45	-57.99%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XFOR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT X4 Pharmaceuticals

X4 Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

16 years

Founded: 2010

2017

Time since IPO - 9 years

72

Employees

X4 Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $536.76 million, with shareholders equity totaling $155.45 million.

The company employs approximately 72 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, X4 Pharmaceuticals Inc. reported $15.85 million in revenue, generating net income of $-90.15 million.

Key financial metrics include a P/E ratio of -5.95, a price-to-book (P/B) ratio of 3.45, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XFOR.

Market cap

$536.76 million

Net worth

$155.45 million

$155,450,000.00

Assets

$253.06 million

$253,060,000.00

Total Shares Outstanding

126.00 million

126,000,000

Average Daily Trading Volume

$826.57 Thousand

$826,570.00

Sector

Health Care

Industry

Biotechnology

XFOR

XFOR revenue and profits

Financial Results XFOR

DRAG THE FRAME TO SEE MORE DATA

XFOR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of X4 Pharmaceuticals (XFOR) today?

A cotação de X4 Pharmaceuticals (XFOR) hoje está em US$ 4.16, com uma variação de 41.98% em relação ao último ano. A cotação de X4 Pharmaceuticals (XFOR) iniciou o ano negociando na casa dos US$ 4.00 e hoje está em US$ 4.16. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de X4 Pharmaceuticals (XFOR) e dados de ações do Ibovespa e mercados internacionais.

Quando X4 Pharmaceuticals (XFOR) paga dividendos?

X4 Pharmaceuticals (XFOR) não distribuiu dividendos no último ano.

Is X4 Pharmaceuticals (XFOR) a good investment?

Atualmente, X4 Pharmaceuticals (XFOR) está cotada a US$ 4.16, com um P/L de -5.95, representando um desvio de -365% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 41.98 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 41.98%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy X4 Pharmaceuticals (XFOR) stock?

Investir em ações de X4 Pharmaceuticals (XFOR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of X4 Pharmaceuticals (XFOR) yield today?

A rentabilidade de X4 Pharmaceuticals (XFOR) foi de 12.74% no último mês, 41.98% no último ano e -97.18% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de X4 Pharmaceuticals (XFOR) hoje, o investimento total seria de US$ 416.00, com base na cotação atual de US$ 4.16.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 590.64
Em 5 anos: US$ 11.73
Em 10 anos: US$ 416.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XFOR

X4 Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XFOR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XFOR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT X4 Pharmaceuticals

X4 Pharmaceuticals Inc.

United States

16 years

2017

72

PROFIT X PRICE XFOR

Financial Results XFOR

XFOR cash flow

Asset, Revenue and Profit Growth - XFOR

XFOR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions